Show simple item record

dc.contributor.authorIravani, Mahmoud M.
dc.contributor.authorAsari, D.
dc.contributor.authorPatel, J.
dc.contributor.authorWieczorek, W. J.
dc.contributor.authorKruk, Z. L.
dc.date.accessioned2013-06-19T09:00:45Z
dc.date.available2013-06-19T09:00:45Z
dc.date.issued2000-06-15
dc.identifier.citationIravani , M M , Asari , D , Patel , J , Wieczorek , W J & Kruk , Z L 2000 , ' Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulate, and the dorsal raphe nucleus slices ' , Synapse: journal & newsletter of the Association of Chartered Physiotherapists Interested in Neurology , vol. 36 , no. 4 , pp. 275-285 .
dc.identifier.issn0887-4476
dc.identifier.otherORCID: /0000-0002-4905-9682/work/32997603
dc.identifier.urihttp://hdl.handle.net/2299/10858
dc.description.abstractWe examined the effects of pressure ejected 3,4-methylenedioxymethamphetamine (MDMA) from a micropipette on direct chemically stimulated release, and on electrically stimulated serotonin (5-HT) or dopamine (DA) release in the caudate putamen (CPu), nucleus accumbens (NAc), substantia nigra pars reticulata (SNr), and the dorsal raphe nucleus (DRN) brain slices of rat, using fast cyclic voltammetry (FCV). MDMA is electroactive, oxidising at +1100 mV. When the anodic input waveform was reduced from +1.4 to +1.0 volt, MDMA was not electroactive. Using this waveform, pressure ejection of MDMA did not release 5-HT or DA in brain slices prepared from any of the nuclei studied. MDMA significantly potentiated electrically stimulated 5-HT release in the SNr and DA release in CPu. In the DRN or in the NAc, MDMA was without effect on peak electrically stimulated 5-HT or DA release. The rates of neurotransmitter uptake, expressed as t(1/2), were in all cases significantly decreased after MDMA. The results indicate that MDMA, unlike (+)amphetamine, is not as a releaser of DA or 5-HT, it is a potent inhibitor of both DA and 5-HT uptake. Synapse 36: 275-285, 2000, (C) 2000 Wiley-Liss, Inc.en
dc.format.extent11
dc.language.isoeng
dc.relation.ispartofSynapse: journal & newsletter of the Association of Chartered Physiotherapists Interested in Neurology
dc.subjectMDMA (ecstasy)
dc.subjectdopamine
dc.subjectserotonin
dc.subjectuptake
dc.subjectfast cyclic voltammetry
dc.subjectcaudate putamen
dc.subjectdorsal raphe nucleus
dc.subjectnucleus accumbens
dc.subjectsubstantia nigra pars reticulata
dc.subjectRAT-BRAIN SLICES
dc.subjectCARRIER-MEDIATED RELEASE
dc.subjectFAST CYCLIC VOLTAMMETRY
dc.subject5-HYDROXYTRYPTAMINE RELEASE
dc.subjectMETHYLENEDIOXYMETHAMPHETAMINE MDMA
dc.subjectSUBSTITUTED AMPHETAMINES
dc.subjectREVERSE TRANSPORT
dc.subjectMICE LACKING
dc.subjectREAL-TIME
dc.subjectNEURONS
dc.titleDirect effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulate, and the dorsal raphe nucleus slicesen
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionCentre for Research in Mechanisms of Disease and Drug Discovery
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.contributor.institutionBasic and Clinical Science Unit
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.description.statusPeer reviewed
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record